文献速递烧伤创面修复显微修复重建

NovoSorb® 可生物降解临时基质(BTM):从首300例连续病例中学到的经验

NovoSorb® Biodegradable Temporising Matrix (BTM): What we learned from the first 300 consecutive cases.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-02-29

本研究纳入2020年3月至2022年10月在本院接受BTM治疗的300例患者(平均年龄54.2±20.1岁,66.3%男性,59.7%烧伤),评估BTM及随后刃厚皮片移植的成活率。BTM平均成活率82.7±25.2%,刃厚皮片平均成活率86.0±22.6%。伤口污染或感染及既往异体皮覆盖似乎会危及BTM和刃厚皮片的良好成活。

要点

  • BTM平均成活率82.7±25.2%,随后刃厚皮片平均成活率86.0±22.6%。
  • 伤口污染或感染及既往异体皮覆盖似乎会危及BTM和刃厚皮片成活。
  • 不同病因的复杂创面若不宜即刻行刃厚皮片移植,可通过两阶段BTM应用及后续植皮成功重建。

核心结论

  • 不同病因的广泛复杂创面若不适合即刻行刃厚皮片移植,可通过两阶段BTM应用及后续植皮成功重建。
  • 伤口污染或感染及既往异体皮覆盖似乎会危及BTM和刃厚皮片的良好成活。

研究设计与样本

  • 纳入2020年3月至2022年10月在本院接受BTM治疗的所有患者。
  • 采用单因素分析和线性回归模型识别BTM及刃厚皮片成活率的预测因素和危险因素。

主要发现

  • 共评估300例患者,平均年龄54.2±20.1岁,66.3%为男性,59.7%为烧伤,19.7%为创伤,20.6%为其他病因。
  • BTM平均成活率为82.7±25.2%,BTM分层后刃厚皮片平均成活率为86.0±22.6%。
  • 多元回归分析显示较高的体重指数(OR 0.43,95%CI 0.86至-0.01,p=0.44)、既往异体皮移植(OR 15.12,95%CI 26.98至-3.31,p=0.041)、较长的创伤至BTM应用间隔(OR 0.01,95%CI 0.001至-0.001,p=0.038)、BTM应用前伤口拭子阳性(OR 7.15,95%CI 13.50至-0.80,p=0.028)及外周动脉疾病(OR 10.80,95%CI 18.63至-2.96,p=0.007)与较差的BTM成活相关。
  • 较高的体重指数(OR 0.40,95%CI 0.76至-0.08,p=0.026)、增大的BTM移植表面积(OR 0.58,95%CI -1.00至-0.17,p=0.005)、既往异体皮(OR 12.20,95%CI -21.99至-2.41,p=0.015)或自体皮移植(OR 22.42,95%CI 38.69至-6.14,p=0.001)、肿瘤作为创面病因(OR 37.42,95%CI 57.41至-17.83,p=0.001)、糖尿病(OR 6.64,95%CI 12.80至-0.48,p=0.035)及肾功能受损(OR 5.90,95%CI 10.94至-0.86,p=0.021)与BTM分层后较差的刃厚皮片成活相关,而较高的BTM成活率与较好的刃厚皮片成活相关(OR 0.40,95%CI 0.31至0.50,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Extensive full-thickness soft-tissue defects remain a challenge in reconstructive surgery. NovoSorb® Biodegradable Temporising Matrix (BTM) represents a novel dermal substitute and was evaluated in wounds deriving from different aetiologies and to highlight risk factors for poor take rates. METHODS: All patients treated with BTM at our department between March 2020 and October 2022 were included. Differences in univariate and linear regression models identified predictors and risk factors for take rates of BTM and split-thickness skin grafts (STSG). RESULTS: Three hundred patients (mean age 54.2 ± 20.1 years, 66.3% male, 59.7% burns, 19.7% trauma and 20.6% others) were evaluated. Mean take rates of BTM and STSG after BTM delamination were 82.7 ± 25.2% and 86.0 ± 22.6%, respectively. Multiple regression analyses showed that higher body mass index (BMI, OR 0.43, 95% CI 0.86, -0.01, p = 0.44), prior allograft transplantation (OR 15.12, 95% CI 26.98, -3.31, p = 0.041), longer trauma-to-BTM-application intervals (OR 0.01, 95% CI 0.001, -0.001, p = 0.038), positive wound swabs before BTM (OR 7.15, 95% CI 13.50, -0.80, p = 0.028) and peripheral artery disease (OR 10.80, 95% CI 18.63, -2.96, p = 0.007) were associated with poorer BTM take. Higher BMI (OR 0.40, 95% CI 0.76, -0.08, p = 0.026), increasing BTM graft surface areas (OR 0.58, 95% CI -1.00, -0.17, p = 0.005), prior allograft (OR 12.20, 95% CI -21.99, -2.41, p = 0.015) or autograft transplantations (OR 22.42, 95% CI 38.69, -6.14, p = 0.001), tumour as the aetiology of the wound (OR 37.42, 95% CI 57.41, -17.83, p = 0.001), diabetes (OR 6.64, 95% CI 12.80, -0.48, p = 0.035) and impaired kidney function (OR 5.90, 95% CI 10.94, -0.86, p = 0.021) were associated with poorer STSG take after delamination of BTM, whereas higher BTM take rates were associated with better STSG take (OR 0.40, 95% CI 0.31,0.50, p < 0.001). CONCLUSION: Extensive complex wounds of different aetiologies unsuitable for immediate STSG can be successfully reconstructed by means of two-staged BTM application and subsequent skin grafting. Importantly, presence of wound contamination or infection and prior allograft coverage appear to jeopardise good BTM and STSG take.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Tapking C, Thomas BF, Hundeshagen G, et al. NovoSorb® Biodegradable Temporising Matrix (BTM): What we learned from the first 300 consecutive cases. J Plast Reconstr Aesthet Surg. 2024. PMID: 38547552. doi:10.1016/j.bjps.2024.02.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。